Alvotech, Teva secure US settlement with Regeneron for Eylea biosimilar launch
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
The initiative is focused on a problem that continues to plague cancer outcomes in India
SGX945 delivered beneficial effects in 7 of 8 patients suffering from painful oral ulcers
USFDA determines Sun Pharma's Baska facility inspection classification as OAI
SandboxAQ will receive an upfront payment and could earn up to $200 million in milestone payments tied to preclinical, development, regulatory, and commercial achievements
This marks the first partnership between Pfizer and Cipla in India
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
Subscribe To Our Newsletter & Stay Updated